Sun Yat-sen University (SYSU), Zhengzhou University, Tianjin Medical University - Tianjin Cancer Institute, Huazhong University of Science and Technology, Nanjing Medical University, University of Ulsan - Asan Medical Center, Macquarie University, Central South University - Hunan Cancer Hospital, Seoul National University, Central South University, Wuhan University, Monash University, Fudan University - Department of Medical Oncology, Yeshiva University - Montefiore/Einstein Center for Cancer Care, China Medical University - Cancer Stem Cell and Translation Medicine Lab, Fujian Medical University - Fujian Cancer Hospital, Seoul National University - Department of Internal Medicine, Chinese Academy of Medical Sciences - National Cancer Center, Shanghai Jiao Tong University (SJTU), PASO Medical, Mary Crowley Cancer Research Center, Sichuan Cancer Hospital, Sun Yat-sen University (SYSU), Shanxi Cancer Hospital, Huazhong University of Science and Technology - Hubei Cancer Hospital, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. and Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation